Status message

Active context: kki_bg_colors_yellow

Research Publications

Kennedy Krieger’s scientists and researchers are leaders in the worldwide effort to prevent and treat disorders of the brain, spinal cord, and musculoskeletal system. Learn about our innovative research initiatives and latest findings through our faculty research publications, Research Frontiers articles, and research press releases.


Nov 28 2017
A drug meant to treat the debilitating seizures of Sturge-Weber syndrome has performed well in a clinical trial at Kennedy Krieger.
Jul 28 2017
Before precision medicine can be used to treat autism, more must be known about the genetic causes of the disorder.
Dec 05 2016
Scientists at Kennedy Krieger search for the key to curing Ellie, while keeping her symptoms at bay.


Apr 21 2016
Baltimore, MD – Kennedy Krieger Institute in Baltimore, MD today helped launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in t
Groundbreaking initiative combines web-based registry with DNA analysis to accelerate autism research and speed discovery of treatments, supports
Nov 23 2015
Baltimore, MD and San Diego, CA – Kennedy Krieger Institute and Viking Therapeutics, Inc.
Kennedy Krieger’s X-ALD Research Group to Evaluate Viking’s Thyroid Beta Agonists, including VK0214
Nov 02 2015
Baltimore, MD – Researchers at the Kennedy Krieger Institute have made a new discovery about the biological functioning of myelin segmen
Discovery Could Improve Understanding of Neurodegenerative Diseases

Bradley L. Schlaggar, M.D., Ph.D., Named President and CEO of Kennedy Krieger Institute

We’re thrilled to welcome Bradley L. Schlaggar, M.D., Ph.D., to the Kennedy Krieger family as our next President and CEO.

Learn more.


Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.